October Pharma SAE (OCPH)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

3 January 2022 09:03 PM October Pharma targets EGP 135m net profits in 2022

Cairo – Mubasher: The board of October Pharma approved the estimated budget for 2022, expecting a net profit after tax worth EGP 135 million by the end of the year. The company also targets sales worth EGP 775 million this year, according to a …

Financial Results

2 November 2021 01:33 PM October Pharma's profit hikes 65% in nine months

Cairo – Mubasher: October Pharma achieved a 65% year-on-year (YoY) increase in its net profits, logging EGP 100.32 million in the first nine months of 2021, compared to EGP 60.67 million.  The revenues levelled up to EGP 489.07 million in the …

Financial Results

13 June 2021 01:37 PM October Pharma’s Q1 profits leap 402%

Cairo – Mubasher: October Pharma recorded a surge of 402% in net profits to EGP 40.59 million during the first quarter (Q1) of 2021, compared to EGP 8.08 million in the same quarter a year ago. Revenues increased by 38% to total EGP 165.83 million …

Financial Results

11 April 2021 02:56 PM October Pharma's shareholders approve dividends, delay bonus issue

Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma approved a cash dividend of 30% of the capital or EGP 3 per share for 2020. The shareholders also decided to postpone the issuance of bonus shares for further consideration, …

General Assembly

11 March 2021 01:38 PM October Pharma profits jump 161% in 2020; dividends, bonus shares proposed

Cairo – Mubasher: October Pharma’s net profits for the year 2020 leapt by 161% on an annual basis, driven by lower production costs and expenses, to reach EGP 88.26 million. Revenue hiked to EGP 543 million last year from EGP 523 million a year …

Cash Dividends

10 December 2020 02:24 PM October Pharma eyes EGP 91.4m profit in FY21 budget

Cairo – Mubasher: The board of October Pharma has approved the estimated budget for fiscal year (FY) 2021. The budget aims to achieve sales of EGP 655 million and after-tax net profits of EGP 91.4 million, according to a stock exchange statement …

Companies Investments

12 November 2020 06:53 PM October Pharma’s profit jumps 227.5% in 9M

Cairo – Mubasher: October Pharma reported a 227.5% year-on-year (YoY) leap in its net profits, registering EGP 60.6 million in the first nine months of 2020, compared to EGP 18.5 million. Revenues grew to EGP 379 million in the January-September …

Financial Results

12 August 2020 03:16 PM October Pharma's profit soars 711% in H1-20

Cairo – Mubasher: The net profits of October Pharma hiked by 711% year-on-year (YoY) to EGP 27 million in the first half (H1) of 2020, compared to EGP 3.33 million. The company’s revenues rose to EGP 244 million in the six-month period ended on 30 …

Financial Results

22 April 2020 04:45 PM October Pharma’s shareholders approve dividends for 2019

Cairo – Mubasher: October Pharma said that its ordinary general meeting (OGM) approved the board’s proposal for cash dividends for the year ended 31 December 2019. The company’s shareholders agreed to distribute EGP 1.5 per share or 15% of the …

Cash Dividends

23 February 2020 04:13 PM October Pharma’s profit leaps 84% in 2019 on higher sales

Cairo – Mubasher: October Pharma reported an 84.6% year-on-year surge in its net profits during 2019 on the back of higher sales. The pharmaceutical company’s net profits hiked to EGP 33.83 million last year from EGP 18.3 million in the previous …

Financial Results

17 February 2020 01:59 PM October Pharma’s indicators show 80% profit hike in 2019

Cairo – Mubasher: October Pharma reported an 80% year-on-year profit surge during 2019 on the back of higher sales, according to the company’s financial indicators. Net profits soared to EGP 32.5 million last year from EGP 18 million in 2018, the …

Financial Results

11 November 2019 05:21 PM October Pharma’s profit rises 19% in 9M unaudited financials

Cairo – Mubasher: The unaudited financial results of October Pharma reported an 18.75% year-on-year increase in its profits during the first nine months of 2019. Net profits amounted to EGP 19 million during the January-September period, compared …

Financial Results

23 September 2019 06:37 PM October Pharma's board approves EGP 60m capital hike

Cairo – Mubasher: The board of directors of October Pharma assented to increase the firm’s capital by EGP 60 million. The company’s issued, paid-up, and authorised capital will be increased to EGP 120 million from EGP 60 million, the company said …

Board of Directors

23 September 2019 06:33 PM October Pharma to close its UAE branch

Cairo – Mubasher: The board of directors of October Pharma approved to close the firm’s unit in the UAE. The board’s decision followed a change in circumstances on which the said branch was established, according to a disclosure to the Egyptian …

Corporate Actions

21 August 2019 02:10 PM October Pharma’s profit drop 67% in H1-19

Cairo- Mubasher: The financial statements of October Pharma indicated a 66.6% year-on-year decline in profits during the first half of 2019. Year-on-year, the profits plunged to EGP 3.33 million in H1-19, when compared to EGP 9.99 million, …

Financial Results

1 April 2019 04:41 PM October Pharma’s OGM nods to EGP 1/shr dividends for 2018

Cairo – Mubasher: October Pharma on Monday announced that its shareholders had approved the board of directors’ proposal to distribute a cash dividend of EGP 1 per share for 2018 during an ordinary general meeting (OGM), according to the firm’s …

Cash Dividends

18 March 2018 11:41 AM October Pharma to discuss UAE unit, dividends Sunday

Cairo – Mubasher: October Pharma’s ordinary general meeting (OGM) will convene on Sunday to discuss the company’s dividend distributions among other items. October Pharma’s board had recommended a cash dividend totalling EGP 24 million, …

Banking and Finance

19 February 2018 04:14 PM October Pharma's profit hikes 60% in 2017

Cairo – Mubasher: October Pharma on Monday reported a 60% year-on-year rise in profits for 2017 due to a growth in revenues. Net profit stood at EGP 56 million last year, up from EGP 35 million in 2016, the company said in a filing to the Egyptian …

Financial Results

25 December 2017 05:18 PM October Pharma targets EGP 480m sales in 2018

Cairo – Mubasher: October Pharma aims at raising its sales by 31% to EGP 480 million in 2018 as part of the company’s budget plan. The target increase in sales does not include Sigma Co’s cosmetics, which made up 10% of the company's last …

Corporate Actions

14 December 2017 00:38 PM 4 Egyptian firms to produce penicillin locally

Cairo – Mubasher: Egypt’s Ministry of Health has assigned four companies to locally produce penicillin, a ministry spokesperson has said. The companies that will be in charge of the local production of the drug are: Nile Pharmaceuticals and …

Ministries

20 April 2017 01:03 PM Record date for October Pharma coupon 8 May

Cairo – Mubasher: October Pharma’s said Thursday that it will pay coupon no. 9 at EGP 3.5 per share to shareholders of record until 8 May. The coupon will be distributed starting 11 May, according to a bourse filing.

Cash Dividends

10 April 2017 01:03 PM October Pharma OGM raises cash dividends to EGP 3.5/shr

Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma has approved to increase cash dividends for fiscal year 2016 to EGP 3.5 from proposed dividends of EGP 3. The OGM also adopted the financial statements for the year ended on 31 …

Cash Dividends

8 March 2017 02:01 PM October Pharma profits surge 119% in 2016

Cairo - Mubasher: The financial indicators of October Pharma have shown a growth in annual profits by 118.8% last year, with a recommendation of distributing cash dividends to shareholders at 30% of the capital. The company’s profits totalled EGP …

Financial Results

24 January 2017 00:16 PM Today: End date for placing orders on October Pharma

Cairo – Mubasher: The Egyptian Exchange announced Tuesday that the span set for buying 7.89% of October Pharma will expire today, according to a bourse statement. Earlier, the bourse opened the OPR market for three days (22-24 January) to sell a …

Corporate Actions

17 November 2016 04:23 PM October Pharma expects EGP50m losses in 2017

Cairo – Mubahser: October Pharma said it expects to incur losses of EGP 50 million in 2017, amid the continuous increase in the production cost. The drug firm studies suspending the production of 30 medicines due to the sharp devaluation of the …

Financial Results